MINTZ STEVEN 4
4 · Serina Therapeutics, Inc. · Filed May 23, 2024
Insider Transaction Report
Form 4
MINTZ STEVEN
Director
Transactions
- Purchase
Common Stock
2024-05-17$8.50/sh+554$4,709→ 554 total(indirect: By Spouse) - Purchase
Common Stock
2024-05-20$9.48/sh+195$1,848→ 749 total(indirect: By Spouse) - Purchase
Common Stock
2024-05-21$10.00/sh+6,651$66,510→ 7,400 total(indirect: By Spouse) - Purchase
Common Stock
2024-05-21$9.75/sh+2,500$24,375→ 9,900 total(indirect: By Spouse) - Purchase
Common Stock
2024-05-20$9.44/sh+1,240$11,702→ 1,240 total(indirect: By Children) - Purchase
Common Stock
2024-05-20$9.42/sh+1,240$11,683→ 1,240 total(indirect: By Children)
Holdings
- 3,307
Common Stock
Footnotes (3)
- [F1]The Reporting Person may be deemed to share voting, investment and dispositive power with respect to these securities. The Reporting Person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.
- [F2]The Reporting Person may be deemed to share voting, investment and dispositive power with respect to these securities. The Reporting Person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.
- [F3]Number of securities determined after giving effect to a reverse split of the Issuer's common stock of 1-for-35.17.